Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GYKI-47261 dihydrochloride is a selective AMPA receptor antagonist, administered orally, and exhibits competitive activity with an IC 50 of 2.5 μM. It displays a wide range of anticonvulsive effects and demonstrates neuroprotective properties. Additionally, GYKI-47261 dihydrochloride is a potent inducer of CYP2E1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | GYKI-47261 dihydrochloride is a selective AMPA receptor antagonist, administered orally, and exhibits competitive activity with an IC 50 of 2.5 μM. It displays a wide range of anticonvulsive effects and demonstrates neuroprotective properties. Additionally, GYKI-47261 dihydrochloride is a potent inducer of CYP2E1. |
In vivo | GYKI-47261 dihydrochloride, administered intravenously at 6 mg/kg, demonstrates an anti-ischemic effect in a rat model of transient focal ischemia. When given orally, it effectively reduces tremors induced by oxotremorine in male CD1 mice, with an ED50 of 16.8 mg/kg. Additionally, an intraperitoneal dose of 20 mg/kg in male C57 black mice (weighing 23-30 g) counteracts the dopamine depletion caused by MPTP, showing a reversal in the reduced striatal concentrations. |
Molecular Weight | 395.71 |
Formula | C18H17Cl3N4 |
CAS No. | 1217049-32-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GYKI-47261 dihydrochloride 1217049-32-5 GYKI-47261 GYKI47261 Dihydrochloride GYKI47261 dihydrochloride GYKI 47261 Dihydrochloride GYKI47261 GYKI 47261 GYKI 47261 dihydrochloride GYKI-47261 Dihydrochloride inhibitor inhibit